Edition:
United Kingdom

AcelRx Pharmaceuticals Inc (ACRX.OQ)

ACRX.OQ on NASDAQ Stock Exchange Global Market

2.05USD
15 Dec 2017
Change (% chg)

$0.10 (+5.13%)
Prev Close
$1.95
Open
$1.95
Day's High
$2.10
Day's Low
$1.95
Volume
72,143
Avg. Vol
215,740
52-wk High
$5.75
52-wk Low
$1.58

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.49 -0.281
Jun '17 2.66 -0.288
Mar '17 3.11 -0.343
FY 2016 Dec '16 6.43 -0.214
Sep '16 3.37 -0.252
Jun '16 4.53 -0.245
Mar '16 3.03 -0.242
FY 2015 Dec '15 1.73 -0.237
Sep '15 15.43 0.113
Jun '15 1.92 -0.201
Mar '15 0.18 -0.229
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 4 3.85 7.80 1.80 2.01
Quarter Ending Mar-18 1 1.90 1.90 1.90 1.50
Year Ending Dec-17 4 11.32 15.00 9.00 7.63
Year Ending Dec-18 4 14.27 30.60 6.90 43.40
Earnings (per share)
Quarter Ending Dec-17 4 -0.20 -0.18 -0.23 -0.26
Quarter Ending Mar-18 1 -0.20 -0.20 -0.20 --
Year Ending Dec-17 4 -1.06 -1.00 -1.14 -1.09
Year Ending Dec-18 4 -1.01 -0.85 -1.13 -0.55
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.66 32.93
P/E High - Last 5 Yrs. -- 290.77 45.62
P/E Low - Last 5 Yrs. -- 93.67 24.34
Beta 3.03 0.85 0.88
Price to Sales (TTM) 14.87 100.68 5.40
Price to Book (MRQ) -- 13.50 5.38
Price to Tangible Book (MRQ) -- 13.43 6.78
Price to Cash Flow (TTM) -- 76.24 23.45
% Owned Institutions 39.70 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -41.32 433.88 9.00
Sales (TTM) vs TTM 1 Yr. Ago -37.00 75.04 5.38
Sales - 5 Yr. Growth Rate 74.52 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -17.56 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -79.25 -- --
EPS - 5 Yr. Growth Rate -- 43.18 10.79
Capital Spending - 5 Yr. Growth Rate 13.00 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 4.81 1.68 2.18
Current Ratio (MRQ) 4.92 5.36 2.98
LT Debt to Equity (MRQ) -- 18.93 11.56
Total Debt to Equity (MRQ) -- 20.59 15.81
Interest Coverage (TTM) -1.82 -111.94 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 13.88 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -225.81 -- --
EBITD - 5 Yr. Avg -161.51 -261.13 15.24
Operating Margin (TTM) -238.47 -556.69 7.76
Operating Margin - 5 Yr. Avg. -170.81 -279.31 10.75
Pre-Tax Margin (TTM) -319.40 -529.93 8.57
Pre-Tax Margin - 5 Yr. Avg. -212.89 -279.05 11.17
Net Profit Margin (TTM) -319.19 -531.37 4.88
Net Profit Margin - 5 Yr. Avg. -213.88 -282.22 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 399,205 25,316,769 864,680,848
Net Income/Employee (TTM) -1,274,205 3,332,346 101,718,394
Receivable Turnover (TTM) 4.98 21.54 5.76
Inventory Turnover (TTM) 9.22 2.01 3.34
Asset Turnover (TTM) 0.16 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -51.83 -0.77 11.00
Return on Assets - 5 Yr. Avg. -34.34 -0.26 12.43
Return on Investment (TTM) -63.23 2.36 14.46
Return on Investment - 5 Yr. Avg. -39.19 2.98 16.28
Return on Equity (TTM) -- 2.96 16.05
Return on Equity - 5 Yr. Avg. -81.78 6.41 17.51
  1 Year 3 Year 5 Year
Sales % -9.89 -16.21 74.52
EPS (TTM) % -72.93 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for AcelRx Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 33.26%
# of Holders: 76
Total Shares Held: 16,740,288
3 Mo. Net Change: -3,734,468
# New Positions: 16
# Closed Positions: 22
# Increased Positions: 31
# Reduced Positions: 41
# Net Buyers: -10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.